NOTES: System: Hundred-Million-Dollar Mud
Finch Therapeutics tried to build a billion-dollar moat out of human waste. Now it's a $17M zombie giant. A look at the hubris of the billion-dollar toilet.
# The Billion-Dollar Toilet: How Finch Therapeutics Flushed a Fortune
Right. Let's talk about Finch Therapeutics. This one’s a special kind of corporate car crash, a real palimpsest of hubris and bad bets, and it reminds me of the oppressive humidity in Shinjuku back in '18—that feeling of unprotected exposure to something fundamentally broken.
They started with a market cap of nearly a billion dollars. Today, it’s a measly $17 million. That’s not a correction, mate. That’s a rounding error.
The Official Story (The Spin)
Finch sold a beautiful story about a “Human-First Discovery platform.” They were developing a “novel class of orally administered biological drugs.”
Translated from corporate rubbish, this means they were trying to put filtered human poop into a pill and sell it as a high-tech cure for gut diseases. They wanted to industrialize the most chaotic, personal ecosystem imaginable. Fair dinkum.
The Real Story (The Grit)
I look at this and I reckon it was always going to be a dog's breakfast. Here’s the actual guts of it:
* There’s Always Money in the Banana Stand: The board operated with the kind of magnificent hubris you only see in sitcoms about dysfunctional families. They genuinely believed they could build a billion-dollar moat out of human waste, forgetting that the raw material changes with every donor’s breakfast. The whole enterprise was completely cactus from the start.
* The Unregulatable Human: Their entire model depended on a steady supply of healthy donors. Then the FDA, spooked by COVID, dropped a regulatory wall on them with screening protocols so expensive it made their supply chain economically impossible. The system couldn’t handle the messy, human variable and simply standardized them out of existence.
* The Human Cost: This isn’t just numbers on a screen. This is a 95% workforce reduction. It's a 203% Debt-to-Equity ratio, which means for every dollar of value, they owe two dollars in debt. They’re a Zombie Giant, a financial black hole now liquidating patents to pay the bills.
The Bottom Line
While Finch was trying to tame the biological chaos, the apex predators like Seres and Vedanta simply bypassed it. They went synthetic, growing their bacterial cocktails in sterile labs, removing the unpredictable human element entirely. They built a product the regulators could understand.
Finch bet the farm on authentic, donor-derived biology. The market, in its infinite wisdom, decided it preferred a clean, manufactured lie to a messy, difficult truth. The ultimate "human-first discovery" they made? In this market, the human is the liability.
